7 results
424B5
PPBT
Purple Biotech Ltd
19 Oct 23
Prospectus supplement for primary offering
10:27am
endanger our clinical trial participants and/or fail to meet established deadlines for the completion of such studies and trials;
If third parties do
F-3/A
PPBT
Purple Biotech Ltd
17 May 23
Shelf registration (foreign) (amended)
5:20pm
, including, but not limited to, failing to conform with quality standards for our therapeutic candidates, which may endanger our clinical trial
F-3
PPBT
Purple Biotech Ltd
7 Dec 22
Shelf registration (foreign)
9:17pm
to, failing to conform with quality standards for our drug candidates, which may endanger our clinical trial participants, recruit clinical trial
20-F/A
rt1s6tdchv3cu0ksj3t
16 Mar 21
Annual report (foreign) (amended)
3:22pm
- Prev
- 1
- Next